Intraoperative asessment of kidney graft quality is critical to predicting short- and long-term transplant outcomes. While Doppler and B-mode ultrasound are widely available and offer non-invasive insights into perfusion and structure, their ability to reliably detect ischemia-reperfusion injury, fibrosis, or other functional impairments at the time of transplant is limited. This leads to inconsistent evaluations of organ viability and may contribute to poorer graft survival,particularly in marginal or deceased donor kidneys. New imaging biomarkers—such as quantitative ultrasound (QUS) and photoacoustic imaging (PAI)—show promise but are not yet adopted in routine surgical workflows.

Join us for an engaging and forward-looking webinar exploring how artificial intelligence is reshaping perinatal ultrasound. From automated fetal measurements to advanced anomaly detection, AI technologies are rapidly becoming integral tools in maternal-fetal medicine. This session will introduce the foundational concepts of AI and machine learning as they apply to ultrasound imaging, highlight real-world clinical applications, and discuss the practical benefits and challenges of integrating these tools into clinical workflows.